MANE

Broke outConviction 87LongHealthcareScan · Fri, Jun 26, 2026

Downtrendchannel

MANE$126.52+5.99%

ResistanceSupportVol 14

Vol MA14 678.35K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Trade plan

Long

Entry

126.52

Risk

Stop

86.48

-31.6% to stop

Reward

Target 1

—

Stretch

Target 2

—

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

Veradermics, IncBiotechnologywww.veradermics.com ↗

Price126.52

Change+5.99%

Gap+0.19%

Rel volume3.56×

Avg volume659.65K

Avg $ vol69.33M

SMA 20100.12

SMA 5098.07

SMA 200—

Price vs 50+29.00%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 97.54

RSI (14)74

MACD hist3.08

MACD crossbull · 3d

Stoch %K / %D96 / 95

ADX (14)22

+DI / −DI33 / 12

RSI divergence—

MACD divergence—

ATR %+6.39%

ADR %7.59%

52w high126.52

52w low37.03

From 52w high+0.00%

Above 52w low+241.67%

New 52w highYes

SqueezeOff

Bollinger width38.85%

%B1.18

Donchian pos96.28%

Donchian high128.06

Donchian low86.83

AVWAP (52w high)123.89

vs AVWAP high+2.12%

AVWAP (52w low)81.29

vs AVWAP low+55.64%

OBV trendUp

Chaikin MF (20)0.18

Today vs 20d3.56×

Avg vol (14d)678.35K

Avg vol (20d)659.65K

Avg $ vol (20d)69.33M

Market cap—

RS 3m (vs SPY)+70.28%

RS 6m (vs SPY)—

RS line new highYes

Trend template—

Technical rank95.8

1 week+34.78%

1 month+26.36%

3 months+87.30%

6 months—

1 year—

YTD+235.15%

P/E-71.17

P/B12.75

P/S—

P/FCF-69.55

EPS-111.91

Div yield—

ROE-17.92%

ROA-17.62%

Debt/Eq—

Current59.12

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-164.25%

Price target136.00

Target upside14.07%

Analyst ratingBuy

Institutional62.40%

Ent. value4.81B

Revenue—

Net income-27.23M

Gross profit—

Free cash flow-71.63M

IndustryBiotechnology

ExchangeNYSE

Shares out41.78M

Employees21

ListedWed, Feb 4, 2026

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction87 / 100

Pattern quality68%

Tech rank95.8 / 100

Group rank50 / 100

Status laneBroke out

Setup directionLong

Pattern familyChannel

Resistance92.47

Support88.51

Days since event4d

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MANE

All disclosures →

No recent disclosed trades by Congress in MANE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MANE · 8 buys

Insider	Side	Shares	Value	Traded	Filed
Cowen Aaron Insider · Pre-Funded Warrants · 2026-05-01	Grant	151K	$15M	2026-05-01	2026-05-05
SUVRETTA CAPITAL MANAGEMENT, LLC Director · Pre-Funded Warrants · 2026-05-01	Grant	149K	$15M	2026-05-01	2026-05-05
Averill Madison Master Fund, Ltd. Director · Pre-Funded Warrants · 2026-05-01	Grant	151K	$15M	2026-05-01	2026-05-05
Cowen Aaron Insider · Pre-Funded Warrants · 2026-05-01	Grant	149K	$15M	2026-05-01	2026-05-05
Averill Madison Master Fund, Ltd. Director · Pre-Funded Warrants · 2026-05-01	Grant	149K	$15M	2026-05-01	2026-05-05
Averill Master Fund, Ltd. Director · Pre-Funded Warrants · 2026-05-01	Grant	149K	$15M	2026-05-01	2026-05-05
Averill Master Fund, Ltd. Director · Pre-Funded Warrants · 2026-05-01	Grant	151K	$15M	2026-05-01	2026-05-05
SUVRETTA CAPITAL MANAGEMENT, LLC Director · Pre-Funded Warrants · 2026-05-01	Grant	151K	$15M	2026-05-01	2026-05-05

SEC filings

EDGAR filings in MANE

EDGAR →

No recent SEC filings on file for MANE.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.